Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/1998
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998CA2275438A1 Improved methods for transducing cells
05/28/1998CA2272073A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/27/1998EP0843565A1 Coarse spray delivery of functional biologic materials
05/27/1998EP0843557A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
05/27/1998EP0666861B1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
05/27/1998EP0596032B1 Induction of cytotoxic t-lymphocyte responses
05/27/1998CN1183046A Composition of tyrosine and polymerised allergen
05/27/1998CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
05/27/1998CN1182622A Injection for curing AIDS and preparation method thereof
05/26/1998US5756764 Drug; proteasome inhibitors
05/26/1998US5756733 Vitamin D amide derivatives
05/26/1998US5756700 Nucleic acid encoding human signal transducer and activator of transcription 4
05/26/1998US5756699 Immunotoxins comprising ribosome-inactivating proteins
05/26/1998US5756695 Methods of synthesizing GM2
05/26/1998US5756492 Graft survival prolongation with porphyrins
05/26/1998US5756466 Inhibitors of interleukin-1β converting enzyme
05/26/1998US5756465 Protease enzyme inhibitors
05/26/1998US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
05/26/1998US5756318 Polysaccharides and preparation thereof
05/26/1998US5756312 Dna molecule encoding polypeptide comprising two heterogeneous amino acid sequences from same variable domain of hepatitis c virus isolates
05/26/1998US5756095 Immunoassays for detection of adhesion molecules
05/26/1998US5756085 Use of interleukin-12 to prevent graft versus host disease
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/22/1998WO1998021344A1 Chimeric ltb vaccines
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021233A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
05/22/1998WO1998021232A2 Mutant forms of fas ligand and uses thereof
05/22/1998WO1998021207A1 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
05/22/1998WO1998021177A1 Benzenesulfonamide derivatives and drugs containing the same
05/22/1998WO1998020902A1 Peptide immunotherapeutic agent
05/22/1998WO1998020879A1 L-β-DIOXOLANE URIDINE ANALOGS AND METHODS FOR TREATING AND PREVENTING VIRUS INFECTIONS
05/22/1998WO1998020873A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
05/22/1998WO1998020868A1 Guanylhydrazones useful for treating diseases associated with t cell activation
05/22/1998WO1998020734A1 Adjuvant for transcutaneous immunization
05/22/1998CA2272404A1 L-.beta.-dioxolane uridine analogs and methods for treating and preventing virus infections
05/22/1998CA2271784A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
05/22/1998CA2271724A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
05/22/1998CA2271699A1 Chimeric ltb vaccines
05/22/1998CA2271673A1 Benzenesulfonamide derivatives and drugs containing the same
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/20/1998EP0843014A2 Tryptophanyl tRNA synthetase
05/20/1998EP0843009A2 A human mytrophin clone hsabh01
05/20/1998EP0842947A2 Hepatitis C virus asialoglycoproteins
05/20/1998EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842282A1 Alfa-beta c4bp-type recombinant heteromultimeric proteins
05/20/1998EP0842266A1 Transgenic swine and swine cells having human hla genes
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842165A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841947A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
05/20/1998EP0841945A1 Cell derived antigen presenting vesicles
05/20/1998EP0841940A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
05/20/1998EP0841939A1 Therapeutic agents and autoimmune diseases
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841927A1 Quinolones and their therapeutic use
05/20/1998EP0841922A1 1h-4(5)-substituted imidazole derivatives
05/20/1998EP0841915A1 Use of ipriflavone to reduce the number of cd8+ cells
05/20/1998EP0841909A2 Use of alicyclic diamines as immunomodulators
05/20/1998EP0841908A1 1,3,3-(trisubstituted)cyclohex-1-ene dimers and related compounds
05/20/1998EP0745083B1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
05/20/1998EP0542860B1 Immunosuppressive compositions
05/20/1998EP0383799B1 Adheson variants
05/20/1998CN1182370A Vaccines containing saponin and sterol
05/20/1998CN1182369A Pharmaceutical compositions for controlled release of soluble receptors
05/20/1998CN1182368A Immanomodulating compositions from bile for treatment of immune system disorders
05/19/1998US5753682 Imidazole lipoxygenase inhibitors
05/19/1998US5753666 Quinolones and their therapeutic use
05/19/1998US5753647 Acylamino-substituted hetrazepines
05/19/1998US5753625 Administering polypeptide
05/19/1998US5753620 Antagonist to tumor necrosis factor and interleukins
05/19/1998US5753480 Cysteinyl tRNA synthetase polynucleotides of streptococcus
05/19/1998US5753479 Genetic enginnering
05/19/1998US5753266 Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
05/19/1998US5753238 Target antigens of transmission blocking antibodies for malaria parasites
05/19/1998US5753235 Recombinant canine herpesviruses
05/19/1998US5753227 Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
05/19/1998CA2007507C Sphingosine and n-methyl-sphingosine as inhibitor of cell growth
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020142A1 Notch
05/14/1998WO1998020023A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998WO1998020013A1 New knoevenagel condensation products, method for their production and their use
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998019999A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
05/14/1998WO1998019706A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998WO1998019689A1 Novel coding sequences
05/14/1998WO1998019676A1 Method for treatment of glutamate related disorders
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998009647A3 Cyanidin compositions and therapeutic and diagnostic uses therefor
05/14/1998WO1998007859A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998005684A3 Mhc binding peptide oligomers and methods of use
05/14/1998WO1998003654A3 High-affinity interleukin-4 muteins
1 ... 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 ... 1172